Cargando…
Efficacy and Safety of Chinese Herbal Medicine on Ovarian Cancer After Reduction Surgery and Adjuvant Chemotherapy: A Systematic Review and Meta-Analysis
Background: Ovarian cancer (OvC) is a malignant tumor which invades ovarian epithelium and interstitium. Reduction surgery combined with adjuvant chemotherapy is standard treatment for OvC patients, but the adverse effects due to chemotherapy still remains a major problem. While Chinese herbal medic...
Autores principales: | Wang, Rongyun, Sun, Qiuhua, Wang, Fang, Liu, Yuan, Li, Xiang, Chen, Tianhui, Wu, Xiaoke, Tang, Huijuan, Zhou, Mengyun, Zhang, Shuzhi, Xiao, Yun, Huang, Weijia, Wang, Chi Chiu, Li, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706872/ https://www.ncbi.nlm.nih.gov/pubmed/31475101 http://dx.doi.org/10.3389/fonc.2019.00730 |
Ejemplares similares
-
Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy
por: Li, Lu, et al.
Publicado: (2021) -
Commentary: Efficacy and Safety of Chinese Herbal Medicine on Ovarian Cancer After Reduction Surgery and Adjuvant Chemotherapy: A Systematic Review and Meta-Analysis
por: Li, Mingxing, et al.
Publicado: (2020) -
Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
por: Chen, Ping, et al.
Publicado: (2022) -
Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Li, Sha, et al.
Publicado: (2020) -
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients
por: Farolfi, Alberto, et al.
Publicado: (2023)